3rd Quarter - Report

ABBVIE, INC. for ABBVIE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,600,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 17, 2014 $1,600,000 Replaced
3rd Quarter - Amendment May 7, 2015 $1,520,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 3474, Hire More Heroes Act of 2014; H.R. 4438, American Research and Competitiveness Act of 2014; H.R. 4464, Permanent CFC Look-Through Act of 2014; S. 2260, Expiring Provisions Improvement, Reform, and Efficiency (EXPIRE) Act of 2014; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced); S. 2360, Stop Corporate Inversions Act of 2014; HR 4679, Stop Corporate Inversions Act of 2014; HR 4985, Stop Corporate Expatriation and Invest in Americas Infrastructure Act of 2014; S. 2786, Corporate Inverters Earnings Stripping Reform Act of 2014; H.R. 5549 and S. 2895, Pay What You Owe Before You Go Act; H.R. 4, Jobs for America Act; H.R. 5278 and S. 2704, No Federal Contracts for Corporate Deserters Act;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —
ADELE R WITENSTEIN —

Contacted: Office of Management & Budget (OMB); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4679 (113th), H.R. 4985 (113th), S. 2786 (113th), S. 2704 (113th), H.R. 4464 (113th), H.R. 5278 (113th), S. 2895 (113th), H.R. 3474 (113th), H.R. 4 (113th), H.R. 5549 (113th), S. 2360 (113th), S. 2260 (113th), H.R. 4438 (113th)

Copyright/Patent/Trademark CPT

S. 1720, Patent Transparency and Improvements Act of 2013; H.R. 3309, Innovation Act; S. 214, Preserve Access to Affordable Generics Act of 2013; H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013; H.R. 3116, MODDERN Cures Act of 2013; H.R. 2985, Combination Drug Development Incentive Act of 2013; various international intellectual property issues and proposals

LobbyistCovered position, as disclosed
JOHN P. FORD —
HEATHER STRAWN —

Contacted: SENATE; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: S. 1720 (113th), H.R. 2985 (113th), H.R. 3709 (113th), H.R. 3309 (113th), S. 214 (113th), H.R. 3116 (113th)

Health Issues HCR

Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA (biosimilars); H.R. 3723, Viral Hepatitis Testing Act of 2013; Proposals to improve viral hepatitis screening and testing; H.R. 3204, Drug Quality & Security Act of 2013; S. 957, Drug Supply Chain Security Act; S. 621, Safe Prescribing Act of 2013; H. R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Discussions to clarify or reform the 340B program; Implementation of The Prescription Drug User Fee Act (PDUFA); H.R. 2031, TEST Act

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —
ADELE R WITENSTEIN —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Bills named: H.R. 3723 (113th), H.R. 1285 (113th), H.R. 3204 (113th), S. 621 (113th), H.R. 2031 (113th), S. 957 (113th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicare; Medicare payment proposals, S. 117 / H.R. 1102, Medicare Prescription Drug Price Negotiation Act of 2013; S. 740 / H.R. 1588, Medicare Drug Savings Act of 2013; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act of 2013;

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
ADELE R WITENSTEIN —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: S. 117 (113th), H.R. 1588 (113th), H.R. 2925 (113th), H.R. 1102 (113th), S. 740 (113th)

Budget/Appropriations BUD

Funding for State AIDS Drug Assistance programs under Ryan White Care Act; S. 1281, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014; H.R. 3547, Consolidated Appropriations Act, 2014; other Labor, Health and Human Services Appropriations; H.R. 2725, Food & Drug Administration Safety Over Sequestration Act of 2013; S. 1413, FDA User Fee Protection Act of 2013; FDAs Changes Being Effected Rule

LobbyistCovered position, as disclosed
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3547 (113th), S. 1281 (113th), H.R. 2725 (113th), S. 1413 (113th)

Trade (domestic/foreign) TRD

A variety of international trade issues including the Trade Promotion Authority, Trans-Pacific Partnership Agreement, Trans-Atlantic Trade and Investment Partnership

LobbyistCovered position, as disclosed
CATHERINE DRATZ FERGUSON —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.